Oxford GlycoSciences H1 Revenues Surge 93 Percent | GenomeWeb

NEW YORK, Sept. 24 – Drug discovery and proteomics company Oxford GlycoSciences of Oxford, UK, said Monday its turnover for the first six months of the year totaled 8.7 million pounds ($12.7 million), compared with 4.5 million pounds in the year ago period. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.